This past trading week (March 19-23) saw a new report from the Canadian government providing more information on the way it intends to regulate cannabis as legalization gets closer to reality. A rebalancing of the premier cannabis ETF and market news complete this Cannabis Weekly Round-Up.

A vote was made on Thursday (March 22) in the Canadian Senate to allow for Bill C-45, the Cannabis Act, to move forward into third reading. The final vote was 44 in favor and 29 against the motion. After voting on the third hearing, if the Senate approves the legislation cannabis will become legal all across Canada.

On Monday (March 19) the Canadian federal government released a report on its conversation with members of the cannabis industry when it comes to regulatory policy. The report can be found online, but some initial takeaways for the public markets relate to packaging issues and financial disclosures.

After the report was presented to the public, some cannabis companies and associations gave some initial feedback on the proposals from the government. Some groups reacted strongly against the government’s packaging rules.

“The packaging requirements proposed today will work against that goal,” Rewak said regarding the need for companies in the space to be allowed and make a clear difference on their products for adult consumers.

Cam Battley, the chief corporate officer of Aurora Cannabis (TSX:ACB; OTC:ACBFF) said the decision to pair cannabis with tobacco, in terms of packaging regulations, was “outrageous and scientifically wrong.”

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

As part of the government’s proposals came the revelation that companies may be expected to disclose financial information from its shareholders during the licensing stage with Health Canada.

According to the document, the government is proposing companies to submit detailed financial information, including investors’ financial information, as a way to keep tabs on who is placing money in the cannabis industry during the licensing process.

“This information could then be used in determining whether to refuse to issue or renew a license… the regulations could require regular, ongoing reporting of financial information by [LPs],” the report said.

Top Cannabis ETF Adds 10 New Stocks

This past week the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) added 10 new holdings into its portfolio as part of a rebalancing expected to take place each quarter.

“It’s exciting to see an increase in the number of investable companies that qualify to be included in HMMJ’s portfolio,” Steve Hawkins, president and Co-CEO of Horizons ETFs said in a statement. The new holdings include:

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Market News

A new report from Marijuana Business Daily found there are, as of February 1, 476 pending applicants for cultivation licenses with Health Canada. The provinces of Ontario and B.C. lead the country in terms of applicants, with 167 and 153 companies respectively.

Despite the high number of production applications, there are only 21 production sites with a sales license as well, Russell Stanley, an analyst with Echelon Wealth Partners told Marijuana Business Daily.

In updates from the US, this past week Cronos Group (NASDAQ:CRON; TSXV:CRON) announced a joint venture with MedMen Enterprises, a company focused on legal cannabis markets in the US. The plan, according to Cronos is for a new operation called MedMen Canada to develop branded products and open stores in the country.

“MedMen stores have been integral to mainstreaming cannabis, and they have become one of the most well-known and respected cannabis platforms in the U.S.,” Cronos CEO Mike Gorenstein said in a statement.

According to the announcement, MedMen Canada will be allowed access to Cronos’ entire production facilities, including any future expansions.

It was revealed Cronos completed a $100 million bought financing deal with BMO Nesbitt Burns, alongside GMP Securities. The deal will get the underwriters 10.4 million Cronos common shares, or 12 million if the over-allotment is taken, at a price of $9.60 a share, according to the Financial Post.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Editorial Disclosure: Beleave, HIKU Brands, Isodiol International are clients of the Investing News Network. This article is not paid-for content.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

** This article is updated each week. Please scroll to the top for the most recent information**

Cannabis Weekly Round-Up: US Operator Launches on the CSE

By Bryan Mc Govern – March 16, 2018

This past trading week (March 12-16) the cannabis markets saw a new company enter the public sector on the Canadian Securities Exchange (CSE). A new study projected the benefits of legalizing marijuana for tax purposes in the US, market news and an interview with Namaste Technologies complete this Cannabis Weekly Round-Up.

The Investing News Network (INN) had the chance to catch up with Sean Dollinger, president, and CEO of Namaste Technologies (CSE:N; OTC:NXTTF), to talk about the company’s plans this year and the progress of their recently launched NamasteMD platform.

“Our whole idea is about being a platform, so LPs place their products on our platform; whereas we are the technology behind it,” Dollinger told INN.

Lawmakers for one of the biggest cannabis markets in the US are exploring the possibility of reducing taxes for the drug as a way to combat the existing illegal market. On Thursday (March 15) the Los Angeles Times reported a group of California lawmakers proposed a reduction of state taxes for three years on growing and selling cannabis.

“We need to give legal businesses some temporary tax relief so they do not continue to be undercut by the black market,” Assemblyman Tom Lackey (R-Palmdale) said. According to the Los Angeles Times, if approved the new legislation wants to cut the state excise tax from 15 to 11 percent, in addition to suspending a cultivation tax of USD$148 per pound.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

A new study projected the benefits a legal framework for cannabis could have on the US economy up to the year 2025. The report, prepared by cannabis research firm New Frontier Data, projected USD$105.6 billion in federal tax revenue benefit for the US by 2025 if marijuana were to be legalized nationwide.

Market News

Aurora Cannabis (TSX:ACB; OTCQB: ACBFF) completed its acquisition for the common shares of CanniMed Therapeutics (TSX:CMED) this week and as such the entire board of directors for CanniMed was replaced. However, it was revealed despite losing his seat on the board, Brent Zettl will continue to be CEO of CanniMed “to ensure a successful transition” for the company and the employees.

GMP Securities analyst Martin Landry issued a note to investors saying he sees Aurora fully valued, even after the CanniMed acquisition.

“By combining with CMED, ACB has evolved into the industry’s largest LP by market cap. with significant platforms to capitalize on both domestic and international growth opportunities,” Landry wrote, according to Cantech Letter. “While we like ACB’s strong balance sheet and growth prospects, we feel these are already reflected in the company’s valuation.

The Green Organic Dutchman Holdings, a private cannabis producer announced this past week it filed an amended and restated preliminary long form prospectus with the securities regulatory authorities as the company prepares for its initial public offering. At the Canaccord Genuity cannabis investor day conference, the company shared with investors it would be preparing for its public launch and revealed it expects to have a completely funded 116,000 kilograms of annual production.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

This past week CannaRoyalty (CSE:CRZ; OTCQX:CNNRF) and National Access Cannabis (NAC) (TSXV:NAC) revealed an upgrade to their partnership in order to set the foundation for a future in which CannaRoyalty can offer its cannabis products in Canada.

Afzal Hasan, executive vice president for corporate development with CannaRoyalty, told INN said the company doesn’t expect this option to materialize anytime soon, but he outlined the ways in which CannaRoyalty could enter the Canadian retail market eventually.

Another cannabis operator with assets in the US began offering its stock to the Canadian market, by launching publicly on the Canadian Securities Exchange. Cannex Capital Holdings (CSE:CNNX) officially started trading on Wednesday (March 14). Anthony Dutton, CEO of Cannex Holdings said in the statement, the CSE listing will give Cannex an opportunity to “build a strong public shareholder base.”

Beacon Securities analyst Vahan Ajamian told Bloomberg Cannex has the “highest trailing revenue” of any US focused cannabis companies in the public market. He also revealed the company raised $48 million as part of a financing deal.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Editorial Disclosure: The Green Organic Dutchman Holdings is a client of the Investing News Network. This article is not paid-for content.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) today announced that Philip Young, CEO and Director, will present virtually at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2021.

Philip Young, CEO and Director will begin his presentation at 10:30 A.M. ET on Wednesday, September 29, 2021.

Keep reading... Show less

Celebrates Canadian launch of the award-winning Keef Brands in Ontario with additional provincial shipments underway

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) is excited to announce the shipment of its award-winning Keef Brands cannabis-infused beverages to the Ontario Cannabis Store (OCS). The Keef products will be available in Ontario retail locations across the province and online at ocs.ca in October 2021 and are also expected to hit British Columbia and Alberta shelves by early November 2021.

Keep reading... Show less

US cannabis received a boost this week with a policy move that may hint at future changes.

Meanwhile, Amazon (NASDQ:AMZN) threw its full support behind cannabis reform in the US by way of a public post confirming the company’s acceptance of the drug.

Keep reading... Show less
  • Research findings originated from cannabinoid-based collaboration with leading epilepsy researcher, Dr. Peter Carlen, at UHN that is also supported by a Mitacs Accelerate program grant.
  • Avicanna’s proprietary formulation showed promising pre-clinical results in reducing seizures and will be developed through the company’s pharmaceutical development pipeline as an epilepsy drug candidate.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals is pleased to announce that it has filed a provisional patent application with the United States Patent and Trademark Office, entitled “Methods for Reducing or Eliminating Incidence of Seizures and Sudden Unexpected Death in Epilepsy”, on the use of a novel cannabinoid formulation (the “ Formulation Candidate ”).

Keep reading... Show less

Cannabis legalization in Canada helped kickstart a financial revolution in the stock market with the launch of a diverse portfolio of marijuana firms.

With the boom of public cannabis businesses in full swing, are you thinking about investing in cannabis companies? If so, consider starting your journey here.

A wide spectrum of marijuana stocks have made their mark in the global industry thanks to the amount of money raised from investors and the attention the sector is getting from established industries.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

What’s to come is anyone’s guess, but it seems this new and burgeoning industry is still in its early days, with diverse nations beginning to move forward with plans for legalizing marijuana.

That means there’s likely still money to be made in cannabis stocks as the market builds and cannabis products expand in availability over the next few years.

There are many differing opinions about how much the global legal cannabis market will be worth in the years to come, with estimates including US$70.6 billion by 2028 and US$91.5 billion by that same year.

But one thing is almost certain: The market is set to grow as opinions surrounding the plant evolve over time and as platforms crop up to supply different consumption preferences. And all of that will mean more cannabis investment opportunities with both existing companies and future entries to the market.

For now, let’s take a look at where you can invest your money at this point in time.

How to invest in cannabis: Canadian cannabis stocks

First thing’s first: Canada. This is the obvious place to start as marijuana is legal at the federal level and Canadian cannabis stocks are less likely than their US counterparts to suffer from political volatility.

That said, due to the uncertainty of investing in the US marijuana space, where the drug is not legal at the federal level, Canadian firms have been forced to make choices about how they operate. For example, Canada’s senior exchanges do not allow companies with American cannabis assets to list.

While the Canadian cannabis space continues to face challenges, investors are eagerly watching as companies move into the edibles and beverages markets and develop new products.

For lists of Canadian marijuana stocks to consider, click here.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

How to invest in cannabis: US cannabis stocks

Although some US states have legalized cannabis, American cannabis stocks may be riskier than those in Canada due to federal restrictions on the sale and cultivation of cannabis.

However, as the saying goes, the greater the risk, the greater the possible reward. The US market could grow up to US$43 billion by 2025, and that’s not even including the size of the market if nationwide legalization happens. It’s easy to see that US cannabis stocks could inherit a huge chunk of the pie if federal law finally legalizes the commodity.

All in all, picking the right US cannabis stocks could mean massive gains if the plant is ultimately legalized federally. It’s worthwhile for investors to do their research and to be aware of the risks and potential benefits involved in investing in the space.

For a list of US cannabis stocks to consider, click here.

How to invest in cannabis: A side note

Many companies in the cannabis space have begun to veer in one direction or another.

For example, some of the largest marijuana producers have moved towards deals with beverage or pharmaceutical companies for the production of novel new products. Others in the space continue to pursue innovation in the recreational market.

The beverage side in particular has seen interest from companies, with cannabis firms partnering with brew businesses. One example is Canopy Growth (NYSE:CGC,TSX:WEED), which has teamed up with Constellation Brands (NYSE:STZ), a leading producer in the alcoholic beverage industry.

It’s important to be aware that each niche has its own possibilities and challenges. For instance, while many market participants are convinced of the promise in beverages, these drinks have been hampered by strict marketing rules, among other factors.

Another aspect to consider is whether to pursue big caps or small caps. That has a lot to do with personal comfort. While big caps are often regarded as more stable than small caps, in the cannabis industry there’s been considerable volatility.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

How to invest in cannabis: Cannabis ETFs

If you really know your cannabis companies, then you could enjoy larger gains by simply investing in those specific firms. However, if you aren’t overly familiar with the cannabis space or you are new to it, it could be a good idea to check out the cannabis exchange-traded funds (ETFs) available.

A cannabis ETF gives you exposure to several different cannabis stocks and takes the guesswork out of cherry picking which stock to bet on. One issue with ETFs is that like any other group dynamic, if one stock drops off it brings the whole fund down proportionally with it. Of course, the opposite is also true.

Recently investors have seen the addition of new ETFs offering exposure to the US market, including firms with entries into the hemp space, thanks to the sales of CBD products.

For a list of cannabis ETFs to consider, click here.

How to invest in cannabis: Final thoughts

No matter which way you slice it — or grind it, in this case — the cannabis market is an exciting business to invest in right now. Whether you invest in cannabis ETFs or Canadian or US marijuana stocks, or if you’re still waiting on the sidelines for more maturity from the types of cannabis companies trading, this industry is one to watch, and one that looks like it’ll keep climbing in the future.

Keep reading... Show less